Reed Willie M
Known title: DirectorCIK: 0001601695
Associated companies
Transaction History
| ZTS | ▲ Buy | Option Exercise | 1,619 | — | 2/19/2026 | View on chart |
| ZTS | ▼ Sell | Open Market | 1,210 | $201K | 3/11/2025 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 1,225 | — | 2/8/2025 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 1,236 | — | 2/6/2025 | View on chart |
| ZTS | ▼ Sell | Open Market | 1,370 | $250K | 3/11/2024 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 1,463 | — | 2/10/2024 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 1,493 | — | 2/8/2024 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 1,626 | — | 2/11/2023 | View on chart |
| ZTS | ▼ Sell | Open Market | 1,855 | $301K | 6/10/2022 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 2,673 | — | 2/12/2022 | View on chart |
| ZTS | ▼ Sell | Open Market | 1,450 | $300K | 8/23/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Goldman Sachs initiates Zoetis coverage with Neutral rating
Goldman Sachs began covering Zoetis with a Neutral rating and a $74 price target. This follows recent guidance cuts that the market initially shrugged off, alongside a new board appointment. The stock currently trades near a key support level, with an RSI of 71.0 indicating strong recent momentum.
Goldman Sachs initiates Zoetis coverage with Neutral rating. Goldman Sachs began covering Zoetis with a Neutral rating and a $74 price target. This follows recent guidance cuts that the market initially shrugged off, alongside a new board appointment. The stock currently trades near a key support level, with an RSI of 71.0 indicating strong recent momentum.